Structure and activity studies of glycine receptor ligands. Part 4. N-[(7-arylalkyl,7-aryloxyalkyl)-8-theophyllyl]-glycines

Polish Journal of Chemistry

Volumn 73, Issue 5, 1999, Pages 783-792

  Drabczynska A ^a   Karolak Wojciechowska, J ^b   Kiec Kononowicz K ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Glycine receptor ligands; N (7 arylalkyl,7 aryloxyalkyl) 8 theophyllyl glycines

Indexed keywords

EID: 0033474988     PISSN: 01375083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Johnson J.W. and Ascher P., Nature, 325, 529 (1987).
2. Smith S.E. and Meldrum B.S., Eur. J. Pharmacol., 211, 109 (1992).
3. Priestley T., Horne A.L., McKerman M.R. and Kemp J.A., Brain Res., 531, 183 (1990).
4. Leeson P.D. and Iversen L.L., J. Med. Chem., 37, 4053 (1994).
5. Leeson P.D., Baker R., Carling R.W., Curtis W.R., Moore K.W., Williams B.J., Foster A.C., Donald A.E., Kemp J.A. and Marshall G.R., J. Med. Chem., 34, 1243 (1991).
6. King F.D., Bermudez D.J. and Sanger G.J., J. Med. Chem., 33, 2944 (1990).
7. Kieć-Kononowicz K., Karolak-Wojciechowska J. and Handzlik J., Acta Pol. Pharm.-Drug Res., 55, 381 (1998)
8. Karolak-Wojciechowska J., Mrozek A., Kwiatkowski W., Ksiazek W., Kieć-Kononowicz K. and Handzlik J., J. Mol Struct., 447, 89 (1998).
9. Drabczyńska A., Pawłowski M., Gorczyca M., Malec D. and Modzelewski J., Polish J. Pharmacol. Pharm., 41, 385 (1989).
10. Pawłowski M., Drabczyńska A., Gorczyca M., Malec D. and Modzelewski J., Polish J. Pharmacol. Pharm., 44, 487 (1992).
11. Drabczyńska A., Pawłowski M., Gorczyca M., Malec D. and Modzelewski J., Pharmazie, 50, 453 (1995).
12. Choi O.H., Shamim M.T., Padgett W.L. and Daly J.W., Life Sci., 43, 387 (1988).
13. Marangos P.J., Paul M.S., Panne A.M., Goodwin F.K., Syapin P. and Skolnick P., Life Sci., 29, 851 (1979).
14. Geis U., Grahner B., Pawłowski M., Drabczyńska A., Gorczyca M. and Müller Ch.E., Pharmazie, 50, 333 (1995).
15. Chojnacka-Wöjcik E., Kłodzińska A., Drabczyńska A., Pawłowski M., Charakchieva-Minol S., Chłó G. and Gorczyca M., Eur. J. Med. Chem., 30, 587 (1995).
16. Genzer J.D., Hutter Ch.P. and von Wessen G.G., J. Am. Chem. Soc., 28, 3159 (1951).
17. Serchi G., Sanchio L. and Bichi G., Il Farmaco Ed. Sc., 10, 732 (1955).
18. Eckstein M., Dissert. Pharm., 214, 411 (1962).
19. Grimwood S., Moseley A.M., Carling M.W., Leeson P.D. and Foster A.C., Mol. Pharmacol., 41, 923 (1992).
20. Kupferberg H.J., Epilepsia, 30 (Suppl. 1), 551 (1989).
21. Porter R.J., Cereghino J.J., Gladding G.D., Hessie B.J., Kupferberg H.J., Scoville B. and White B.C., Cleveland Clin. Q., 51, 293 (1984).
22. Lothman B.W., Salerno R.A., Perlin J.B. and Kaiser D.L., Epilepsy Res., 2, 367 (1988).
23. Lothman E.W. and Williamson J.M., Brain Res., 71, 649 (1994).
24. MT, Siemens Analytical X-Ray Instruments Inc. Madison, Wisconsin, USA (1990).
25. Sheldrick G.M., SHELXL-93. A FORTRAN-77 Program for the Refinement of Crystal Structures from Difraction Data. Univ. of Göttingen, Germany (1993).
26. PCMODEL.6 Molecular Modelling Software for the IBM PC, Serena Software, Bloomington, (1996).